Lawrence J Hirsch Selected Research

Midazolam (Versed)

5/2019	Seizure cluster: Definition, prevalence, consequences, and management.
1/2019	Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit.
3/2016	Treatment of Convulsive Status Epilepticus.
1/2014	High-dose midazolam infusion for refractory status epilepticus.
7/2002	The current state of treatment of status epilepticus.
2/2002	Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lawrence J Hirsch Research Topics

Disease

32	Seizures (Absence Seizure) 01/2022 - 02/2002
27	Epilepsy (Aura) 01/2022 - 12/2002
17	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 02/2002
7	Critical Illness (Critically Ill) 01/2022 - 09/2009
7	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 12/2002
5	Drug Resistant Epilepsy 11/2017 - 07/2006
3	Encephalitis (Encephalitis, Rasmussen) 03/2014 - 09/2012
2	Coma (Comas) 02/2021 - 09/2017
2	Cognitive Dysfunction 01/2021 - 01/2018
2	Generalized Epilepsy 10/2020 - 01/2017
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2018 - 01/2014
2	Hypotension (Low Blood Pressure) 03/2016 - 07/2015
2	Brain Injuries (Brain Injury) 04/2010 - 09/2009
2	Migraine Disorders (Migraine) 11/2006 - 01/2006
2	Exanthema (Rash) 11/2006 - 02/2006
2	Neuralgia (Stump Neuralgia) 11/2006 - 01/2006
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Ischemic Stroke 01/2022
1	Myoclonus (Nocturnal Myoclonus) 10/2021
1	Neurologic Manifestations (Neurological Manifestations) 10/2021
1	Ataxia (Dyssynergia) 10/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 10/2021
1	Gaucher Disease (Gaucher's Disease) 10/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 05/2021
1	Disease Progression 01/2019
1	Glioma (Gliomas) 01/2018
1	Sepsis (Septicemia) 09/2017
1	Hippocampal Sclerosis 01/2017
1	Idiopathic Generalized Epilepsy 01/2017
1	Cerebral Hemorrhage 10/2016
1	Hypersensitivity (Allergy) 03/2016
1	Drug Hypersensitivity (Drug Allergy) 03/2016
1	Tachycardia (Tachyarrhythmias) 07/2015
1	Ventricular Fibrillation 07/2015
1	Hemiplegia (Spastic Hemiplegia) 04/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2014
1	Sudden Unexpected Death in Epilepsy 01/2013

Drug/Important Bio-Agent (IBA)

22	Anticonvulsants (Antiepileptic Drugs)IBA 10/2020 - 02/2002
6	Anesthetics (Anesthetic Agents)IBA 01/2022 - 07/2002
6	Pharmaceutical PreparationsIBA 02/2021 - 12/2002
6	Midazolam (Versed)FDA LinkGeneric 05/2019 - 02/2002
5	Lamotrigine (Lamictal)FDA LinkGeneric 01/2013 - 09/2005
4	BenzodiazepinesIBA 05/2019 - 07/2005
4	AntibodiesIBA 01/2018 - 01/2014
4	Levetiracetam (Keppra)FDA LinkGeneric 03/2016 - 12/2002
3	Phenytoin (Dilantin)FDA LinkGeneric 01/2018 - 09/2005
2	Lacosamide FDA Link 01/2018 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2018 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2010
2	SodiumIBA 01/2018 - 01/2007
2	Propofol (Diprivan)FDA LinkGeneric 07/2002 - 02/2002
1	EnzymesIBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Vigabatrin FDA Link 01/2022
1	Prostaglandins BIBA 01/2022
1	Pregabalin (Lyrica)FDA Link 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Calcium Channels (Calcium Channel)IBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2021
1	miglustat (Zavesca)FDA Link 10/2021
1	Glucosylceramides (Glucocerebrosides)IBA 10/2021
1	GlycosphingolipidsIBA 10/2021
1	Antisense OligonucleotidesIBA 05/2021
1	dimemorfan (AT 17)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Lorazepam (Ativan)FDA LinkGeneric 01/2019
1	Hypnotics and Sedatives (Sedatives)IBA 12/2018
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2018
1	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	AlbuminsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Isoflurane FDA LinkGeneric 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	lead selenideIBA 11/2017
1	N 30IBA 09/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	CannabidiolIBA 03/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2015
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 05/2015
1	Amobarbital (Amsal)IBA 04/2015
1	salicylhydroxamic acid (SHAM)IBA 03/2014
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2014
1	Ketamine FDA LinkGeneric 08/2013

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2002
7	Critical Care (Surgical Intensive Care) 01/2019 - 07/2003
4	Electrodes (Electrode) 10/2020 - 11/2004
3	Vagus Nerve Stimulation 12/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 05/2021 - 08/2014
2	Immunotherapy 01/2018 - 01/2014
1	Neurosurgical Procedures 01/2022
1	Decompressive Craniectomy 01/2022
1	Deep Brain Stimulation 12/2021
1	Ketogenic Diet 02/2021
1	Ovariectomy (Oophorectomy) 02/2021
1	Length of Stay 12/2018
1	Topical Administration 01/2018
1	Contraindications 03/2016